{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:51:44Z","timestamp":1791341504887,"version":"4.3.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:00:00Z","timestamp":1791331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"European Union within the Slovakia Programme for the project Innovative trends in the treatment of respiratory diseases","award":["ITMS21+: 401101C648"],"award-info":[{"award-number":["ITMS21+: 401101C648"]}]},{"name":"European Union within the Slovakia Programme for the project Innovative trends in the treatment of respiratory diseases","award":["ITMS21+: 401101C648"],"award-info":[{"award-number":["ITMS21+: 401101C648"]}]},{"name":"European Union within the Slovakia Programme for the project Innovative trends in the treatment of respiratory diseases","award":["ITMS21+: 401101C648"],"award-info":[{"award-number":["ITMS21+: 401101C648"]}]},{"DOI":"10.13039\/501100006109","name":"Vedeck\u00e1 Grantov\u00e1 Agent\u00fara M\u0160VVa\u0160 SR a SAV","doi-asserted-by":"publisher","award":["1\/0026\/25"],"award-info":[{"award-number":["1\/0026\/25"]}],"id":[{"id":"10.13039\/501100006109","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lung"],"DOI":"10.1007\/s00408-026-00947-2","type":"journal-article","created":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:07:42Z","timestamp":1791338862000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Phenotype-Guided Surfactant Therapy in ARDS: From Failed Replacement to Targeted Biological Intervention, Narrative Review"],"prefix":"10.1007","volume":"204","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1596-3702","authenticated-orcid":false,"given":"Petra","family":"Hornakova Kosutova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5273-6422","authenticated-orcid":false,"given":"Maria","family":"Belancova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8485-4748","authenticated-orcid":false,"given":"Pavol","family":"Mikolka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,7]]},"reference":[{"issue":"7511","key":"947_CR1","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0140-6736(67)90168-7","volume":"2","author":"DG Ashbaugh","year":"1967","unstructured":"Ashbaugh DG, Bigelow DB, Petty TL, Levine BE (1967) Acute respiratory distress in adults. Lancet 2(7511):319\u2013323","journal-title":"Lancet"},{"key":"947_CR2","doi-asserted-by":"publisher","first-page":"e076612","DOI":"10.1136\/bmj-2023-076612","volume":"387","author":"KD Wick","year":"2024","unstructured":"Wick KD, Ware LB, Matthay MA (2024) Acute respiratory distress syndrome. BMJ 387:e076612","journal-title":"BMJ"},{"issue":"23","key":"947_CR3","first-page":"2526","volume":"307","author":"ADT Force","year":"2012","unstructured":"Force ADT, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E et al (2012) Acute respiratory distress syndrome: the Berlin definition. JAMA 307(23):2526\u20132533","journal-title":"JAMA"},{"issue":"1","key":"947_CR4","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1164\/rccm.202303-0558WS","volume":"209","author":"MA Matthay","year":"2024","unstructured":"Matthay MA, Arabi Y, Arroliga AC, Bernard G, Bersten AD, Brochard LJ et al (2024) A new global definition of acute respiratory distress syndrome. Am J Respir Crit Care Med 209(1):37\u201347","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"947_CR5","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1007\/s00134-023-07050-7","volume":"49","author":"G Grasselli","year":"2023","unstructured":"Grasselli G, Calfee CS, Camporota L, Poole D, Amato MBP, Antonelli M et al (2023) ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies. Intensive Care Med 49(7):727\u2013759","journal-title":"Intensive Care Med"},{"issue":"1","key":"947_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1164\/rccm.202311-2011ST","volume":"209","author":"N Qadir","year":"2024","unstructured":"Qadir N, Sahetya S, Munshi L, Summers C, Abrams D, Beitler J et al (2024) An update on management of adult patients with acute respiratory distress syndrome: an official American thoracic society clinical practice guideline. Am J Respir Crit Care Med 209(1):24\u201336","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"947_CR7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1186\/rr86","volume":"2","author":"A Gunther","year":"2001","unstructured":"Gunther A, Ruppert C, Schmidt R, Markart P, Grimminger F, Walmrath D et al (2001) Surfactant alteration and replacement in acute respiratory distress syndrome. Respir Res 2(6):353\u2013364","journal-title":"Respir Res"},{"issue":"1","key":"947_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1203\/00006450-199907000-00015","volume":"46","author":"BA Holm","year":"1999","unstructured":"Holm BA, Wang Z, Notter RH (1999) Multiple mechanisms of lung surfactant inhibition. Pediatr Res 46(1):85\u201393","journal-title":"Pediatr Res"},{"issue":"3 Pt 1","key":"947_CR9","first-page":"L286","volume":"262","author":"W Seeger","year":"1992","unstructured":"Seeger W, Gunther A, Thede C (1992) Differential sensitivity to fibrinogen inhibition of SP-C- vs. SP-B-based surfactants. Am J Physiol 262(3 Pt 1):L286\u2013L291","journal-title":"Am J Physiol"},{"issue":"7","key":"947_CR10","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1183\/09031936.93.06070971","volume":"6","author":"W Seeger","year":"1993","unstructured":"Seeger W, Grube C, Gunther A, Schmidt R (1993) Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations. Eur Respir J 6(7):971\u2013977","journal-title":"Eur Respir J"},{"issue":"1","key":"947_CR11","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1378\/chest.09-0787","volume":"136","author":"RG Spragg","year":"2009","unstructured":"Spragg RG, Taut FJH, Gunther A, Rippin G (2009) Surfactant replacement therapy in ARDS. Chest 136(1):321\u2013322","journal-title":"Chest"},{"key":"947_CR12","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1146\/annurev.physiol.65.092101.142434","volume":"65","author":"JF Lewis","year":"2003","unstructured":"Lewis JF, Veldhuizen R (2003) The role of exogenous surfactant in the treatment of acute lung injury. Annu Rev Physiol 65:613\u2013642","journal-title":"Annu Rev Physiol"},{"issue":"2","key":"947_CR13","doi-asserted-by":"publisher","first-page":"R41","DOI":"10.1186\/cc4851","volume":"10","author":"WJ Davidson","year":"2006","unstructured":"Davidson WJ, Dorscheid D, Spragg R, Schulzer M, Mak E, Ayas NT (2006) Exogenous pulmonary surfactant for the treatment of adult patients with acute respiratory distress syndrome: results of a meta-analysis. Crit Care 10(2):R41","journal-title":"Crit Care"},{"issue":"6","key":"947_CR14","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/cc11512","volume":"16","author":"A Dushianthan","year":"2012","unstructured":"Dushianthan A, Cusack R, Goss V, Postle AD, Grocott MP (2012) Clinical review: Exogenous surfactant therapy for acute lung injury\/acute respiratory distress syndrome\u2013where do we go from here? Crit Care 16(6):238","journal-title":"Crit Care"},{"issue":"1","key":"947_CR15","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3892\/etm.2012.746","volume":"5","author":"LN Zhang","year":"2013","unstructured":"Zhang LN, Sun JP, Xue XY, Wang JX (2013) Exogenous pulmonary surfactant for acute respiratory distress syndrome in adults: a systematic review and meta-analysis. Exp Ther Med 5(1):237\u2013242","journal-title":"Exp Ther Med"},{"issue":"1","key":"947_CR16","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12890-018-0761-y","volume":"19","author":"SS Meng","year":"2019","unstructured":"Meng SS, Chang W, Lu ZH, Xie JF, Qiu HB, Yang Y et al (2019) Effect of surfactant administration on outcomes of adult patients in acute respiratory distress syndrome: a meta-analysis of randomized controlled trials. BMC Pulm Med 19(1):9","journal-title":"BMC Pulm Med"},{"key":"947_CR17","doi-asserted-by":"publisher","first-page":"103645","DOI":"10.1016\/j.resp.2021.103645","volume":"288","author":"F Cattel","year":"2021","unstructured":"Cattel F, Giordano S, Bertiond C, Lupia T, Corcione S, Scaldaferri M et al (2021) Use of exogenous pulmonary surfactant in acute respiratory distress syndrome (ARDS): role in SARS-CoV-2-related lung injury. Respir Physiol Neurobiol 288:103645","journal-title":"Respir Physiol Neurobiol"},{"issue":"1","key":"947_CR18","doi-asserted-by":"publisher","first-page":"20946","DOI":"10.1038\/s41598-023-47672-x","volume":"13","author":"A Dushianthan","year":"2023","unstructured":"Dushianthan A, Clark HW, Brealey D, Pratt D, Fink JB, Madsen J et al (2023) A randomized controlled trial of nebulized surfactant for the treatment of severe COVID-19 in adults (COVSurf trial). Sci Rep 13(1):20946","journal-title":"Sci Rep"},{"issue":"4","key":"947_CR19","first-page":"5141","volume":"123","author":"DG Sweet","year":"2026","unstructured":"Sweet DG, Carnielli VP, Greisen G, Hallman M, Klebermass-Schrehof K, Lavizzari A et al (2026) European consensus guidelines on the management of respiratory distress syndrome: 2025. Neonatology 123(4):514","journal-title":"Neonatology"},{"issue":"6","key":"947_CR20","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1172\/JCI115523","volume":"88","author":"TJ Gregory","year":"1991","unstructured":"Gregory TJ, Longmore WJ, Moxley MA, Whitsett JA, Reed CR, Fowler AA et al (1991) Surfactant chemical composition and biophysical activity in acute respiratory distress syndrome. J Clin Invest 88(6):1976\u20131981","journal-title":"J Clin Invest"},{"issue":"6","key":"947_CR21","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1097\/MAJ.0b013e318239c96c","volume":"343","author":"MC Seeds","year":"2012","unstructured":"Seeds MC, Grier BL, Suckling BN, Safta AM, Long DL, Waite BM et al (2012) Secretory phospholipase A2-mediated depletion of phosphatidylglycerol in early acute respiratory distress syndrome. Am J Med Sci 343(6):446\u2013451","journal-title":"Am J Med Sci"},{"issue":"suppl1","key":"947_CR22","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/milmed\/usx204","volume":"183","author":"M Al-Saiedy","year":"2018","unstructured":"Al-Saiedy M, Gunasekara L, Green F, Pratt R, Chiu A, Yang A et al (2018) Surfactant Dysfunction in ARDS and Bronchiolitis is Repaired with Cyclodextrins. Mil Med 183(suppl1):207\u2013215","journal-title":"Mil Med"},{"issue":"4","key":"947_CR23","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1164\/rccm.201607-1401LE","volume":"195","author":"JB Grotberg","year":"2017","unstructured":"Grotberg JB, Filoche M, Willson DF, Raghavendran K, Notter RH (2017) Did Reduced Alveolar Delivery of Surfactant Contribute to Negative Results in Adults with Acute Respiratory Distress Syndrome? Am J Respir Crit Care Med 195(4):538\u2013540","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"947_CR24","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1056\/NEJMoa033181","volume":"351","author":"RG Spragg","year":"2004","unstructured":"Spragg RG, Lewis JF, Walmrath HD, Johannigman J, Bellingan G, Laterre PF et al (2004) Effect of recombinant surfactant protein C-based surfactant on the acute respiratory distress syndrome. N Engl J Med 351(9):884\u2013892","journal-title":"N Engl J Med"},{"issue":"1","key":"947_CR25","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1152\/japplphysiol.00850.2025","volume":"140","author":"KG Lee","year":"2026","unstructured":"Lee KG, Greendyk RA, Goligher EC (2026) Surfactant therapy for the treatment of acute respiratory distress syndrome: time to revisit? J Appl Physiol (1985) 140(1):303\u2013321","journal-title":"J Appl Physiol (1985)"},{"issue":"22","key":"947_CR26","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1056\/NEJM199605303342201","volume":"334","author":"A Anzueto","year":"1996","unstructured":"Anzueto A, Baughman RP, Guntupalli KK, Weg JG, Wiedemann HP, Raventos AA et al (1996) Aerosolized surfactant in adults with sepsis-induced acute respiratory distress syndrome. Exosurf Acute Respiratory Distress Syndrome Sepsis Study Group. N Engl J Med 334(22):1417\u20131421","journal-title":"N Engl J Med"},{"issue":"4","key":"947_CR27","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1164\/ajrccm.155.4.9105072","volume":"155","author":"TJ Gregory","year":"1997","unstructured":"Gregory TJ, Steinberg KP, Spragg R, Gadek JE, Hyers TM, Longmore WJ et al (1997) Bovine surfactant therapy for patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 155(4):1309\u20131315","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"947_CR28","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1164\/rccm.200207-782OC","volume":"167","author":"RG Spragg","year":"2003","unstructured":"Spragg RG, Lewis JF, Wurst W, Hafner D, Baughman RP, Wewers MD et al (2003) Treatment of acute respiratory distress syndrome with recombinant surfactant protein C surfactant. Am J Respir Crit Care Med 167(11):1562\u20131566","journal-title":"Am J Respir Crit Care Med"},{"key":"947_CR29","first-page":"18","volume":"13","author":"A Dushianthan","year":"2023","unstructured":"Dushianthan A, Grocott MPW, Murugan GS, Wilkinson TMA, Postle AD (2023) Pulmonary surfactant in adult ARDS: current perspectives and future directions. Diagnostics (Basel) 13:18","journal-title":"Diagnostics (Basel)"},{"issue":"8","key":"947_CR30","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/S2213-2600(14)70097-9","volume":"2","author":"CS Calfee","year":"2014","unstructured":"Calfee CS, Delucchi K, Parsons PE, Thompson BT, Ware LB, Matthay MA et al (2014) Subphenotypes in acute respiratory distress syndrome: latent class analysis of data from two randomised controlled trials. Lancet Respir Med 2(8):611\u2013620","journal-title":"Lancet Respir Med"},{"issue":"7","key":"947_CR31","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1164\/rccm.202002-0347OC","volume":"202","author":"P Sinha","year":"2020","unstructured":"Sinha P, Churpek MM, Calfee CS (2020) Machine learning classifier models can identify acute respiratory distress syndrome phenotypes using readily available clinical data. Am J Respir Crit Care Med 202(7):996\u20131004","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"947_CR32","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1007\/s00134-018-5378-3","volume":"44","author":"P Sinha","year":"2018","unstructured":"Sinha P, Delucchi KL, Thompson BT, McAuley DF, Matthay MA, Calfee CS et al (2018) Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study. Intensive Care Med 44(11):1859\u20131869","journal-title":"Intensive Care Med"},{"issue":"4","key":"947_CR33","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.ccm.2014.08.004","volume":"35","author":"CM Shaver","year":"2014","unstructured":"Shaver CM, Bastarache JA (2014) Clinical and biological heterogeneity in acute respiratory distress syndrome: direct versus indirect lung injury. Clin Chest Med 35(4):639\u2013653","journal-title":"Clin Chest Med"},{"issue":"2","key":"947_CR34","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/joim.12845","volume":"285","author":"J Johansson","year":"2019","unstructured":"Johansson J, Curstedt T (2019) Synthetic surfactants with SP-B and SP-C analogues to enable worldwide treatment of neonatal respiratory distress syndrome and other lung diseases. J Intern Med 285(2):165\u2013186","journal-title":"J Intern Med"},{"issue":"2","key":"947_CR35","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/pr.2016.231","volume":"81","author":"F Ricci","year":"2017","unstructured":"Ricci F, Murgia X, Razzetti R, Pelizzi N, Salomone F (2017) In vitro and in vivo comparison between poractant alfa and the new generation synthetic surfactant CHF5633. Pediatr Res 81(2):369\u2013375","journal-title":"Pediatr Res"},{"issue":"24","key":"947_CR36","doi-asserted-by":"publisher","first-page":"4739","DOI":"10.1080\/14767058.2020.1863363","volume":"35","author":"DG Sweet","year":"2022","unstructured":"Sweet DG, Turner M, Stranak Z, Plavka R, Clarke P, Stenson B et al (2022) A first-in-human clinical study of a new SP-B and SP-C enriched synthetic surfactant (CHF5633) in preterm babies with respiratory distress syndrome: two-year outcomes. J Matern Fetal Neonatal Med 35(24):4739\u20134742","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"12","key":"947_CR37","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1080\/17476348.2024.2429669","volume":"18","author":"FJ Walther","year":"2024","unstructured":"Walther FJ, Zasadzinski JA, Waring AJ (2024) What is new in synthetic lung surfactant protein technology? Expert Rev Respir Med 18(12):913\u2013917","journal-title":"Expert Rev Respir Med"},{"issue":"1","key":"947_CR38","doi-asserted-by":"publisher","first-page":"e14700","DOI":"10.14814\/phy2.14700","volume":"9","author":"P Mikolka","year":"2021","unstructured":"Mikolka P, Curstedt T, Feinstein R, Larsson A, Grendar M, Rising A et al (2021) Impact of synthetic surfactant CHF5633 with SP-B and SP-C analogues on lung function and inflammation in rabbit model of acute respiratory distress syndrome. Physiol Rep 9(1):e14700","journal-title":"Physiol Rep"},{"issue":"3","key":"947_CR39","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s00408-024-00689-z","volume":"202","author":"P Mikolka","year":"2024","unstructured":"Mikolka P, Kosutova P, Kolomaznik M, Nemcova N, Hanusrichterova J, Curstedt T et al (2024) The synthetic surfactant CHF5633 restores lung function and lung architecture in severe acute respiratory distress syndrome in adult rabbits. Lung 202(3):299\u2013315","journal-title":"Lung"},{"key":"947_CR40","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.trsl.2023.07.009","volume":"262","author":"P Mikolka","year":"2023","unstructured":"Mikolka P, Kronqvist N, Haegerstrand-Bjorkman M, Jaudzems K, Kosutova P, Kolomaznik M et al (2023) Synthetic surfactant with a combined SP-B and SP-C analogue is efficient in rabbit models of adult and neonatal respiratory distress syndrome. Transl Res 262:60\u201374","journal-title":"Transl Res"},{"issue":"1","key":"947_CR41","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12931-019-1220-x","volume":"20","author":"J Zebialowicz Ahlstrom","year":"2019","unstructured":"Zebialowicz Ahlstrom J, Massaro F, Mikolka P, Feinstein R, Perchiazzi G, Basabe-Burgos O et al (2019) Synthetic surfactant with a recombinant surfactant protein C analogue improves lung function and attenuates inflammation in a model of acute respiratory distress syndrome in adult rabbits. Respir Res 20(1):245","journal-title":"Respir Res"},{"issue":"1","key":"947_CR42","doi-asserted-by":"publisher","first-page":"17930","DOI":"10.1038\/s41598-019-54480-9","volume":"9","author":"Y Montigaud","year":"2019","unstructured":"Montigaud Y, Georges Q, Pourchez J, Leclerc L, Goy C, Clotagatide A et al (2019) Aerosol delivery during invasive mechanical ventilation: development of a preclinical ex vivo respiratory model for aerosol regional deposition. Sci Rep 9(1):17930","journal-title":"Sci Rep"},{"issue":"2","key":"947_CR43","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1164\/rccm.202107-1690CP","volume":"205","author":"RK Albert","year":"2022","unstructured":"Albert RK (2022) Constant Vt ventilation and surfactant dysfunction: an overlooked cause of ventilator-induced lung injury. Am J Respir Crit Care Med 205(2):152\u2013160","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"947_CR44","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s13054-019-2365-1","volume":"23","author":"P van der Zee","year":"2019","unstructured":"van der Zee P, Gommers D (2019) Recruitment maneuvers and higher PEEP, the so-called open lung concept, in patients with ARDS. Crit Care 23(1):73","journal-title":"Crit Care"},{"issue":"4","key":"947_CR45","doi-asserted-by":"publisher","first-page":"L554","DOI":"10.1152\/ajplung.00355.2024","volume":"328","author":"F Possmayer","year":"2025","unstructured":"Possmayer F, Veldhuizen RAW, Jobe AH (2025) Reflections on the introduction of surfactant therapy for neonates with respiratory distress. Am J Physiol Lung Cell Mol Physiol 328(4):L554\u2013L63","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"947_CR46","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.bcp.2019.03.036","volume":"164","author":"B Baer","year":"2019","unstructured":"Baer B, Souza LMP, Pimentel AS, Veldhuizen RAW (2019) New insights into exogenous surfactant as a carrier of pulmonary therapeutics. Biochem Pharmacol 164:64\u201373","journal-title":"Biochem Pharmacol"},{"key":"947_CR47","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.trsl.2025.05.009","volume":"281","author":"P Kosutova","year":"2025","unstructured":"Kosutova P, Nemcova N, Kolomaznik M, Calkovska A, Mikolka P (2025) A novel rabbit model of severe ARDS: synergistic effects of acid aspiration and harmful mechanical ventilation. Transl Res 281:43\u201354","journal-title":"Transl Res"},{"key":"947_CR48","doi-asserted-by":"crossref","unstructured":"Boyle AJ, Greendyk RA, Rochwerg B, McAuley DF, Goligher EC (2026) Optimizing endpoints in early phase clinical trials of acute respiratory distress syndrome. Am J Respir Crit Care Med","DOI":"10.1093\/ajrccm\/aamag238"}],"container-title":["Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-026-00947-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00408-026-00947-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00408-026-00947-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T02:07:49Z","timestamp":1791338869000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00408-026-00947-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,7]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["947"],"URL":"https:\/\/doi.org\/10.1007\/s00408-026-00947-2","relation":{},"ISSN":["1432-1750"],"issn-type":[{"value":"1432-1750","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,7]]},"assertion":[{"value":"17 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"During the preparation of this work the authors used Perplexity.ai to improve the readability and language quality of the text. After using this tool\/service, the authors reviewed and edited the content as needed and take full responsibility for the content of the published article.","order":2,"name":"Ethics","label":"Declaration of Generative AI and AI-assisted Technologies in the Writing Process","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"82"}}